Translational strategies in aging and age-related disease

Nat Med. 2015 Dec;21(12):1395-9. doi: 10.1038/nm.4004.

Abstract

Aging is a risk factor for several of the world's most prevalent diseases, including neurodegenerative disorders, cancer, cardiovascular disease and metabolic disease. Although our understanding of the molecular pathways that contribute to the aging process and age-related disease is progressing through the use of model organisms, how to apply this knowledge in the clinic is less clear. In September, Nature Medicine, in collaboration with the Volkswagen Foundation, hosted a conference at the beautiful Herrenhausen Palace in Hannover, Germany with the goal of broadening our understanding of the aging process and its meaning as a 'risk factor' in disease. Here, several of the speakers at that conference answer questions posed by Nature Medicine.

Publication types

  • Interview

MeSH terms

  • Aging / physiology*
  • Animals
  • Biomarkers / metabolism
  • Caloric Restriction
  • Clinical Trials as Topic
  • Disease*
  • Environment
  • Humans
  • Life Style
  • Longevity / physiology
  • Models, Animal
  • Translational Research, Biomedical*

Substances

  • Biomarkers